stockportfolio.pro
AMGN vs ISRG: Which Stock Is the Better Buy?
Amgen Inc. and Intuitive Surgical, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — AMGN vs ISRG, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| Amgen Inc. (AMGN) | Intuitive Surgical, Inc. (ISRG) | |
|---|---|---|
| Market cap | $201.9B | $150.9B |
| Revenue (latest FY) | $36.75B | $10.06B |
| Net income (latest FY) | $7.71B | $2.86B |
| Revenue growth (5y CAGR) | 7.6% | 18.2% |
| Net margin | 21.0% | 28.4% |
| Return on equity | 89.1% | 16.0% |
| P/E ratio | 26.0 | 51.8 |
| Dividend yield | 2.7% | — |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full AMGN vs ISRG breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open AMGN's full financials → Open ISRG's full financials →More comparisons
Frequently asked questions
Which is bigger, AMGN or ISRG?
Amgen Inc. is larger by market capitalization — $201.9B versus $150.9B.
Which grows faster, AMGN or ISRG?
Over the last five fiscal years, Intuitive Surgical, Inc. grew revenue faster — 18.2%/yr versus 7.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.